Page last updated: 2024-10-22

aminoglutethimide and Hypergonadotropic Hypogonadism

aminoglutethimide has been researched along with Hypergonadotropic Hypogonadism in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horký, K2
Küchel, O2
Gregorvá, I1
Stárka, L2
Gregorová, I1

Trials

1 trial available for aminoglutethimide and Hypergonadotropic Hypogonadism

ArticleYear
Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:2

    Topics: 17-Ketosteroids; Adrenocortical Hyperfunction; Aminoglutethimide; Androsterone; Aniline Compounds; A

1969

Other Studies

1 other study available for aminoglutethimide and Hypergonadotropic Hypogonadism

ArticleYear
Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone.
    Metabolism: clinical and experimental, 1971, Volume: 20, Issue:3

    Topics: 17-Ketosteroids; Adult; Aminoglutethimide; Androsterone; Aniline Compounds; Anticonvulsants; Dehydro

1971